Saving Minds

Latest Episodes:

Episode 6 – The "One-Two Punch" of Abeta and Tau May 28, 2019

Show notes

Toxic tau and amyloid-beta are the two most validated drug targets for an Alzheimers disease therapy. Elliot and Shanti discuss tau, its role as a root cause of Alzheimer's disease and its involvement in 80 other diseases known as tauopathies.

Episode 5 – Major Late-stage Alzheimer's Failures May 25, 2019

Show notes

Dr. Goldstein and Shanti breakdown the news of the week. This week they discuss two major late-stage failures for promising Alzheimer's drugs, a new syndrome that is similar to Alzheimer's, and some important biomarker developments.

Episode 4 – How do Biomarkers Work? Mar 27, 2019

Show notes

This is part two of our exploration of biomarkers. Elliot and Shanti discuss how biomarkers work and how they will play a critical role in the future of drug development for the various brain-wasting diseases.

Episode 3 – Why Biomarkers Matter Mar 15, 2019

Show notes

Dr. Goldstein and Shanti discuss why biomarkers are becoming increasingly important in the medical community. They also discuss how biomarkers are uniquely important in the quest for a cure for Alzheimer's.

Episode 2 – Understanding Parkinson's Disease Mar 11, 2019

Show notes

This week Dr. Goldstein and Shanti discuss Parkinson's disease. They discuss the underlying cause of Parkinson's, treatment options, side effects and the connection between Parkinson's and Alzheimer's

Episode 1 – The Alzheimer's Public Health Crisis Feb 24, 2019

Show notes

This week our hosts Dr. Elliot Goldstein MD and Shanti Skiffington provide a summary of the current efforts to find a cure for Alzheimer's disease.

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected